Benserazide Hydrochloride

盐酸苄丝肼

Report date: 2023/11/30 11:28:17
NME

Base Information

Drug NameBenserazide Hydrochloride
Drug Alias NameBenserazideRo-4-4602
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDDC gene transferenceDOPA decarboxylase inhibitors
TargetsAromatic-L-amino-acid decarboxylase
Therapy Area/Indicationsbeta-ThalassemiaAnemia, Sickle CellDyskinesias +[4] 
Global Approved IndicationsDyskinesiasParkinson Disease
Approved Indications in ChinaDyskinesiasParkinson Disease
Original Approved Country/TerritoryMainland China
Original Approved Date1995/01/01
Country/TerritoryCanadaUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesPhoenicia Biosciences IncShanghai Yishengyuan Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active Indicationsbeta-ThalassemiaAnemia, Sickle CellDyskinesias +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksDrugBankKEGG